Baudax Bio, Inc.

BXRX · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$59-$20-$76-$33
Dep. & Amort.$2$3$3$0
Deferred Tax$0-$2$17$0
Stock-Based Comp.$1$5$9$5
Change in WC-$0-$3$1-$9
Other Non-Cash$28-$32$3-$15
Operating Cash Flow-$28-$49-$44-$50
Investing Activities
PP&E Inv.-$0-$0-$1-$1
Net Acquisitions$0-$0$0$0
Inv. Purchases$0-$20$0$0
Inv. Sales/Matur.$0$20$0$0
Other Inv. Act.$0$0$0-$0
Investing Cash Flow-$0-$0-$1-$1
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$20$31$45$0
Stock Repurch.-$0-$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$17$35$57$69
Financing Cash Flow$17$35$57$69
Forex Effect$0$0$0$0
Net Chg. in Cash-$11-$14$13$18
Supplemental Information
Beg. Cash$16$30$18$0
End Cash$5$16$30$18
Free Cash Flow-$28-$49-$45-$52
Baudax Bio, Inc. (BXRX) Financial Statements & Key Stats | AlphaPilot